Alzheimer’s: Gene Therapy Restores Memory in Mice
- A new gene therapy developed at the University of California San Diego School of Medicine offers a potential breakthrough in the fight against Alzheimer's disease. Researchers are optimistic...
- Unlike current Alzheimer's treatments that focus on managing symptoms by targeting protein deposits, this gene therapy aims to influence the behavior of brain cells themselves, potentially halting or...
- In studies involving mice, researchers discovered that administering the gene therapy at the symptomatic stage preserved hippocampal-dependent memory, a crucial aspect of cognitive function frequently enough impaired by...
UC San Diego unveils a groundbreaking gene therapy that may revolutionize Alzheimer’s treatment. This innovative approach targets the root causes of the disease, perhaps safeguarding the brain from damage and preserving cognitive function. Early studies highlight notable results: mice treated at the symptomatic stage exhibited preserved memory, mirroring gene expression patterns of healthy counterparts. This is a monumental leap forward.This gene therapy, licensed to Eikonoklastes Therapeutics, offers a novel way to influence brain cells. Addressing the global impact of Alzheimer’s,this research offers a beacon of hope. Further human clinical trials are needed, though the potential is clear. News Directory 3 is following this closely. Discover what’s next as we explore the future of Alzheimer’s treatment.
Gene Therapy Shows Promise for Alzheimer’s cognitive Function
Updated June 25, 2025
A new gene therapy developed at the University of California San Diego School of Medicine offers a potential breakthrough in the fight against Alzheimer’s disease. Researchers are optimistic that this innovative approach coudl protect the brain from damage adn preserve cognitive function by addressing the underlying causes of the disease.
Unlike current Alzheimer’s treatments that focus on managing symptoms by targeting protein deposits, this gene therapy aims to influence the behavior of brain cells themselves, potentially halting or even reversing the progression of the disease. Alzheimer’s affects millions worldwide, leading to brain cell death and declines in memory and cognitive abilities.
In studies involving mice, researchers discovered that administering the gene therapy at the symptomatic stage preserved hippocampal-dependent memory, a crucial aspect of cognitive function frequently enough impaired by Alzheimer’s. Treated mice exhibited gene expression patterns similar to healthy mice, suggesting the therapy’s potential to restore diseased cells to a healthier state and improve cognitive decline.
What’s next
While human clinical trials are still needed, this gene therapy represents a promising avenue for mitigating cognitive decline and promoting overall brain health. the technology has been licensed to Eikonoklastes Therapeutics, wich received FDA Orphan Drug Designation for its use in amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease.